Upstream / Downstream

Explore pathways related to this product.

Antibody Guarantee

CST Antibody Performance Guarantee

LEARN MORE  

To Purchase # 1036S

1036S 100 µg $79.00
$ 0. 00

Questions?

Find answers on our FAQs page.

ANSWERS  

Visit PhosphoSitePlus®

PTM information and tools available.

LEARN MORE

Immunohistochemical analysis of paraffin-embedded Non-Hodgkin's lymphoma, using PU.1 (9G7) Rabbit mAb #2258 in the presence of control peptide (left) or PU.1 Blocking Peptide (right).

Learn more about how we get our images
Image

Product Description

This peptide is used to specifically block PU.1 Antibody #2266 and PU.1 (9G7) Rabbit mAb #2258 reactivity.


Quality Control

The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry. The peptide blocks PU.1 Antibody #2266 and PU.1 (9G7) Rabbit mAb #2258 by immunohistochemistry.

Product Usage Information

Use as a blocking reagent to evaluate the specificity of antibody reactivity in immunohistochemistry protocols. For immunohistochemistry, add twice the volume of peptide as volume of antibody used in 100 µl total volume. Incubate for a minimum of 30 minutes prior to adding the entire volume to the slide. Recommended antibody dilutions can be found on the relevant product data sheet.


Storage: Supplied in 20 mM potassium phosphate (pH 7.0), 50 mM NaCl, 0.1 mM EDTA, 1 mg/ml BSA and 5% glycerol. Store at –20°C.

PU.1 is a member of the Ets family of transcription factors and activates target genes through the purine-rich PU-box (1). PU.1 plays a pivotal role in the differentiation of myeloid cells and lymphocytes and is expressed in several hematopoietic cells including B lymphocytes, macrophages, neutrophils, mast cells, early erythroid cells and megakaryocytes (1,2). The concentration of PU.1 is critical for both the determination of hematopoietic cell lineage and the regulation of differentiation versus stem cell proliferation (3,4). In addition, PU.1 activity is influenced by phosphorylation and interactions with other hematopoietic transcription factors. Phosphorylation of PU.1 at Ser146 by CK2 promotes binding to IRF4 and synergistic activation through the immunoglobulin κ 3' enhancer (5). Treatment of pro-B cells with IL-3 leads to phosphorylation of PU.1 at Ser140, resulting in increased PU.1 activity and activation of the anti-apoptotic gene MCL-1 (6). GATA1 binding blocks PU.1 activity during erythroid cell development (7). Overexpression of PU.1 resulting from proviral insertion during Friend virus infection can induce erythroleukemia, while reduced expression has been associated with acute myeloid leukemia (8).


1.  Lloberas, J. et al. (1999) Immunol. Today 20, 184-189.

2.  Klemsz, M.J. et al. (1990) Cell 61, 113-124.

3.  Dahl, R. and Simon, M.C. (2003) Blood Cells Mol. Dis. 31, 229-233.

4.  DeKoter, R.P. and Singh, H. (2000) Science 288, 1439-1441.

5.  Pongubala, J.M. et al. (1993) Science 259, 1622-1625.

6.  Wang, J.M. et al. (2003) Mol. Cell Biol. 23, 1896-1909.

7.  Zhang, P. et al. (1999) Proc. Natl. Acad. Sci. USA 96, 8705-8710.

8.  Moreau-Gachelin, F. et al. (1998) Nature 331, 277-280.


Entrez-Gene Id 6688
Swiss-Prot Acc. P17947


For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.